Studying cancer treatment in the elderly patient population

Cancer Control

Volumn 21, Issue 3, 2014, Pages 215-220

  Balducci, Lodovico ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; OBINUTUZUMAB; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; AGEISM; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; DAILY LIFE ACTIVITY; DISEASE FREE SURVIVAL; GERIATRIC ASSESSMENT; HUMAN; LARGE CELL LYMPHOMA; LIFE EXPECTANCY; OVERALL SURVIVAL; PATIENT PARTICIPATION; POLYPHARMACY; UNSPECIFIED SIDE EFFECT; AGE; CLINICAL TRIAL (TOPIC); FEMALE; MALE; NEOPLASMS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84903196452     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481402100306     Document Type: Article

References (32)

1. Balducci L, Aapro M. Complicated and complex: helping the older cancer patients to exit the labyrinth. J Ger Oncol. 2014;5(1):116-118.
2. Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence, and types of mild anemia in the elderly: the "Health and Anemia" population-based study. Hematologica. 2010;95(11):1849-1856.
3. Hurria A, Wildes T, Blair ST, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(1):82-126.
4. Yourman LG, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182-192.
5. Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefits into prevention decisions for older adults. JAMA. 2013;310(24):2609-2610.
6. Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118(13):3377-3386.
7. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457-3465.
8. Balducci L, Goetz-Parten D, Steinman MA. Polypharmacy and the management of the older cancer patient. Ann Oncol. 2013;(24 suppl 7):vii36-40.
9. Mohile SG, Fan L, Reeve E, et al. Association of cancer and geriatric syndromes in older Medicare beneficiaries. J Clin Oncol. 2011;29(11): 1458-1464.
10. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;(9 suppl 2):S51-S63.
11. Mitnitski A, Song X, Rockwood K. Assessing biological aging: the origin of deficit accumulation. Biogerontology. 2013;14(6):709-717.
12. Huffman KM, Pieper CF, Kraus VB, et al. Relations of a marker of endothelial activation (s-VCAM) to function and mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2011;66(12):1369-1375.
13. Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35(1): 112-131.
14. Falandry C, Gilson E, Rudolph KL. Are aging biomarkers clinically relevant in oncogeriatrics? Crit Rev Oncol Hematol. 2013;85(3):257-265.
15. Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179-4187.
16. Turner N, Zafarana E, Becheri D, et al. Breast cancer in the elderly: which lessons have we learned? Future Oncol. 2013;9(12):1871-1881.
17. Balducci L, Ershler WB. Cancer and aging: a nexus at several levels. Nat Rev Cancer. 2005;5(8):655-662.
18. Evans JL, Goldfine ID. Aging and insulin resistance: just say iNOS. Diabetes. 2013;62(2):346-348.
19. Velarde MC, Demaria M, Campisi J. Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol. 2013; 38:17-27.
20. Margel D, Urbach DR, Lipscombe LI, et al. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. J Clin Oncol. 2013;31(25):3069-3075.
21. Chlebowski RT, McTiernan A, Wactawski-Wende J, et al. Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol. 2012;30(23):2844-2852.
22. Hoffe S, Balducci L. Cancer and age: general considerations. Clin Geriatr Med. 2012;28(1):1-18.
23. Tadmor T, McLaughlin P, Polliack A. Chemoimmunotherapy with fludarabine, cytoxan and rituximab regimen: to use, not to use, or give it as "FCR-LITE"? Leuk Lymphoma. 2014;55(4):733-734.
24. Freedman VA. Research gaps in the demography of aging with disability. Disabil Health J. 2014;7(1 suppl):S60-S63.
25. Kemeny MM, Peterson BL, Komblith AB, et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003;21(12):2268-2275.
26. Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360(20): 2055-2065.
27. Meoni G, Cecere FL, Lucherini E, et al. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents. J Geriatr Oncol. 2013;4(3):282-290.
28. Bastion Y, Blay JY, Divine M, et al. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival-a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol. 1997;15(8):2945-2953.
29. Goede V, Fischer K, Busch R, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014;370(12): 1101-1110.
30. Sanoff HK, Carpenter WR, Stürmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30(21):2624-2634.
31. Lyman GH, Dale DC, Wolff DA, et al. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. J Clin Oncol. 2010;28(17):2914-2924.
32. American Society of Clinical Oncology. CancerLinQ. http://www.asco.org/quality-guidelines/cancerlinq. Accessed April 22, 2014.